PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsThrombophlebitis
MeSH D013924 - thrombophlebitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010689:Phlebitis
0 Companies
0 Drugs
Success rate
D020246:Venous thrombosis
28 Companies
11 Drugs
$
Success rate
D013924: 
Thrombophlebitis
44 Companies
8 Drugs
$
Success rate
D057831:Lemierre syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Taro PharmaceuticalWarfarin Warfarin  1999-07-15   
MylanHeparin Heparin  2017-11-30   
CiplaWarfarin Warfarin  2011-05-25   
SandozHeparin Heparin  2011-06-08   
Aspen GlobalHeparin Liquaemin  1982-01-01   
NovartisHeparin, Lidocaine, Dihydroergotamine Embolex  1984-11-30   
SanofiHeparin Calciparine  1982-01-01   
3MHeparin Lipo-hepin  1982-01-01   
PfizerDalteparin Fragmin  1994-12-22 $238 M Y2023 
Heparin Heparin  1982-01-01   
Eli LillyHeparin Heparin  1982-01-01   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
25%
1/4
Phase 2
0%
0/0
Phase 3
78%
7/9
Approved: 5Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Aspen Global
Heparin,
Heparin sodium
Novartis
Heparin,
Lidocaine,
Dihydroergotamine,
Heparin sodium,
Diclophenac
Sanofi
Enoxaparin,
Enoxaparin sodium,
Heparin,
Heparin sodium
Pfizer
Heparin,
Dalteparin,
Heparin sodium,
Dalteparin sodium,
Dexibuprofen,
Lysine,
Lmwh
Eli Lilly
Heparin,
Heparin sodium
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use